Selv om den kliniske betydning af inducerede antistoffer ikke er fuldt belyst, er udvikling af neutraliserende antistoffer forbundet med reduceret effekt af kliniske og MRIvariabler.
Although the clinical significance of the induction of antibodies has not been fully elucidated, the development of neutralising antibodies is associated with reduced efficacy on clinical and MRI variables.